We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
21 hedge funds and large institutions have $1.11M invested in Cardiff Oncology in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
22% more capital invested
Capital invested by funds: $915K → $1.11M (+$198K)
6.14% more ownership
Funds ownership: 1.25% → 7.39% (+6.1%)
19% less funds holding
Funds holding: 26 → 21 (-5)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Holders
21
Holders Change
-5
Holders Change %
-19.23%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
3
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$164K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$73.4K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
+$37.1K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$33.7K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$8.4K |
